Clinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Migraine
Interventions
DEVICE

transcranial direct stimulation

Mars-01(Marslab, Turkey) transcranial direct current stimulation device works with a 9 volt battery and consists of two 5x5 (25 cm2) electrodes (anode and cathode). 3 consecutive sessions (days), cathodal to occipital cortex (O1 or O2, ipsilateral); Anodal application will be made to M1 (left). Active stimulation is 2mA tDCS with a 0 to 30 second acceleration period of 20 minutes per session. Placebo stimulation will be applied according to the device's own sham software protocol. Accordingly, the current consists of 30 seconds of increase from 0 to 2mA(milliamp), 10 seconds of stimulation, 30 seconds of decrease to 0 and 20 minutes of current-free application.

DEVICE

Sham treatment

The same device used for stimulation will be used, but no stimulation will be given.

Trial Locations (1)

33333

İstanbul Medipol University, Istanbul

All Listed Sponsors
collaborator

Alanya Alaaddin Keykubat University

OTHER

collaborator

Saglik Bilimleri Universitesi

OTHER

lead

Istanbul Medipol University Hospital

OTHER

NCT06468189 - Clinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine | Biotech Hunter | Biotech Hunter